[1]
V. Nade, V. Ahire, L. Kawale, and B. Siraskar, “In-Silico and In-Vivo Evaluation of Luteolin and Imeglimin as Novel Therapeutic Agents in Reserpine-Induced Parkinsons Disease in Rats: Neuroprotective effects of luteolin and Imeglimin in reserpine-induced Parkinsons disease in rats”, Iran J Pharm Sci, vol. 22, no. 1, pp. 223–235, Jun. 2026.